期刊文献+

p16蛋白在经胎盘诱发大鼠脑肿瘤不同时期的表达 被引量:1

p16 protein expression in the transplacental induced brain tumor in rat
原文传递
导出
摘要 目的 利用亚硝基乙基脲 (ENU)经胎盘诱发大鼠脑肿瘤的模型 ,对肿瘤发生前、后各阶段p16蛋白表达进行连续动态观察。方法 对该模型出生后 6 0d、90d、12 0d、15 0d的子代鼠脑进行p16蛋白免疫组化染色观察。结果  (1) 6 0d组的p16蛋白均表达阳性 ,无缺失发生 ;90d组偶有阴性 ;12 0d组阳性率下降 ;15 0d组阳性率明显下降。瘤周组织的阳性表达率高于瘤内组织。 (2 )p16蛋白主要定位于细胞核 ,极少部分定位于细胞浆。结论  (1)随着本模型肿瘤发生率的增加 ,大鼠脑内p16蛋白的表达下降 ,说明p16基因突变过程正是肿瘤的发生发展时期 ,p16基因活动下降与本模型胶质瘤的发生发展有关。(2 )p16蛋白定位主要位于细胞核内 。 Objective To study in series the p16 protein expression on the rat brain tumor induced transplacentally by ENU Methods The p16 protein expression was determined with immuno histochemistry stain on the offspring′s brain at their 60,90,120,150 days after birth Results (1) p16 proteins were expressed in all of the brain samples in the 60 day group; occasionally negative in the 90 day group; partly expressed in the 120 day group; significantly less expressed in the 150 day group (2) The rate of expression in the tissue around tumor was higher than that in the tumor (3) The p16 protein was mainly orientated in the nuclear of cell and sporadically orientated in the cytoplasm Conclusion (1)It shows the p16 protein expression decreases with the increase of tumor incidence in the rat brain, which accompanies the start and development of the induced tumor So we speculate that the dysfunction of p16 gene is one of the factors related to tumor incidence in this animal model (2) The p16 protein is mainly orientated in the nuclear of cell and sporadically orientated in the cytoplasm
出处 《中华外科杂志》 CAS CSCD 北大核心 2004年第6期358-361,共4页 Chinese Journal of Surgery
基金 国家自然科学基金资助项目(39770751)
关键词 P16蛋白 胎盘 诱发 大鼠 脑肿瘤 表达 神经胶质瘤 免疫组织化学 Protein p16 Glioma Immunohistochemistry
  • 相关文献

参考文献2

二级参考文献11

  • 1Rasheed BKA, Mclendon RE, Herndon JE, et al. Alterations of the Tp53 gene in human gliomas [J]. Cancer Res, 1994,54 (109): 1324-1330.
  • 2Harvey M,McArthur MJ,Montgomery CA,et al. Spotaneous and carcinogen-induced tumorigenesis in p53-deficient mice[J]. Nat Genet,1993,5 (1): 225-229.
  • 3Cho MY,Jung SH, Kim TS,et al. p53 protein overexpression in astrocytic neoplasms[J] .J Yousei Med, 1995,36(3) :521 - 525.
  • 4Yaziji H, Wafai RM, Gujrati M, et al. Role of p53 immunohistochemistry in differentiating reactive gliosis from malignant astrocytic lesions[J] .Am J Surg Pathol, 1996,20(12): 1086 - 1090.
  • 5Kleihues P,Schauble B,Hausen A,et al.Tumors associated with p53 germline mutations. A synopsis of 91 families[J]. Am J Pathol, 1997,150(1):1 - 13.
  • 6Frederick FL,Alfred Y,Raymond S,et al. Adenovirus-mediated p53 gene therapy for human gliomas[J]. Neurosurgery, 1999,45(4):1093-1104.
  • 7Louis DN. The p53 gene and protein in human brain tumor [J]. J Neuropathol Exp Neurol, 1994,53 ( 1 ): 11 - 21.
  • 8Hagel C, Laking G, Laas G, et al. Demonstration of p53 protein and Tp53 gene mutations in oligodendrogliomas[J]. Eur J Cancer, 1996,32(11) :2242 - 2248.
  • 9Bogler O, Huang HJ, Cavenee WK. Loss of wild-type p53 bestows a growth advantage on primary cortical astrocytes and facilitates their in vitro transformation[J] .Cancer Res,1995,55(32):2746-2751.
  • 10Marx J. How p53 suppressor cell growth [J]. Science, 1993, 262(335): 1644 - 1645.

共引文献1

同被引文献34

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部